Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

Several lines of emerging data point to an imbalance between neuronal excitation and inhibition in at least a subgroup of individuals with autism spectrum disorder (ASD), including in those with fragile X syndrome (FXS), one of the most common genetic syndromes within ASD. In animal models of FXS an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacology
Main Authors: Veenstra-VanderWeele, Jeremy, Cook, Edwin H, King, Bryan H, Zarevics, Peter, Cherubini, Maryann, Walton-Bowen, Karen, Bear, Mark F, Wang, Paul P, Carpenter, Randall L
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436109/
https://ncbi.nlm.nih.gov/pubmed/27748740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados